The ECMC’s Complex Innovative Design (CID) trial consensus paper was published in January 2020 and has since been one of the BJC’s most popular downloads. At the time of its publication the authors were unaware that the pandemic was only weeks away and that complex innovative design (CID) studies like RECOVERY would become household names in combatting COVID-19. In honour of BJC’s recent 75th anniversary the writing group has recently published a follow-up commentary. We invited the authors to discuss these publications and the future for CID trials.
Read about the work of the ECMC Programme Office to promote the ECMC network externally and building relationships with not just with Pharma, Biotech, Medtech and CROs but with key stakeholders including our sites, regulators and the various teams within the NIHR infrastructure who engage with industry.
Improving the efficiency of trial set-up and delivery has been identified as a key priority in the Saving and Improving Lives: The Future of UK Clinical Research Delivery, launched in 2021. The ECMC network has initiated, in partnership with the Health Research Authority (HRA), a project which aims to develop and test revised approaches to set-up of early-phase trials within the ECMC Network.
We're pleased to launch new and informative webpages that will help you navigate the new research regulatory landscape.
Interview with Professor Deborah Tweddle Professor of Paediatric Oncology at Newcastle
Interview with Dr Lynley Marshall, Oak Foundation Consultant in Paediatric and Adolescent Oncology Drug Development at The Royal Marsden Hospital